Does ABROCITINIB Cause Product dose omission issue? 52 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Product dose omission issue have been filed in association with ABROCITINIB (CIBINQO). This represents 1.6% of all adverse event reports for ABROCITINIB.
52
Reports of Product dose omission issue with ABROCITINIB
1.6%
of all ABROCITINIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product dose omission issue From ABROCITINIB?
Of the 52 reports.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABROCITINIB. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does ABROCITINIB Cause?
Drug ineffective (398)
Condition aggravated (316)
Off label use (269)
Therapeutic product effect incomplete (186)
Pruritus (171)
Rash (134)
Nausea (130)
Dermatitis atopic (110)
Headache (85)
Acne (73)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ABROCITINIB Alternatives Have Lower Product dose omission issue Risk?
ABROCITINIB vs ACALABRUTINIB
ABROCITINIB vs ACAMPROSATE
ABROCITINIB vs ACARBOSE
ABROCITINIB vs ACCUTANE
ABROCITINIB vs ACEBUTOLOL